Clinical Laboratory in North Carolina

Novex Innovations is a contract development and manufacturing organization (CDMO) specializing in the design, development, and commercialization of biologics, pharmaceuticals, medical devices, and bioengineered tissue. Operating a 36,000 square-foot cGMP-compliant facility with Class 100 and Class 1,000 cleanroom spaces, the company provides comprehensive services spanning product and process development, clinical and commercial manufacturing, regulatory support, and distribution. Capabilities include biological formulations, clinical formulation, tissue processing, active pharmaceutical development, diagnostic materials manufacturing, and inventory management. ISO 13485 certified and FDA-registered, Novex supports clients from proof-of-concept through all phases of clinical trials to commercial scale-up and market distribution, serving both startups and multinational organizations across national and international markets.

Cedarlane specializes in supplying high-quality research reagents, diagnostic antibodies, kits, chemicals, and consumables to the life science community. The company operates as a distributor providing access to over 1,400 industry-leading global life science suppliers manufacturing products across all research areas. Product offerings include antibodies, arrays, assays and ELISA kits, cell lines, cloning reagents, enzymes, equipment, isotype controls, media and cell culture products, molecular biology products, primary cells, proteins and peptides, small molecules/inhibitors, transfection/transformation reagents, lab animal supplies, microbiology products, and specialty chemicals. Cedarlane serves academic institutions, research centers, universities, and diagnostic laboratories across North America. The company is part of TCP Analytical, a portfolio of chemical, research reagent, and laboratory product companies operating in the USA and Canada. Cedarlane emphasizes convenience to customers by handling import/regulatory issues and providing technical support alongside online ordering capabilities. The company maintains a customer-focused approach with dedicated technical service teams and streamlined e-commerce operations.

SARSTEDT AG & Co. KG is a global manufacturer and distributor of laboratory consumables and sample-handling products for clinical diagnostics, life science research, and laboratory automation. The company operates four primary business divisions: preanalytics (blood, urine, fecal, and saliva collection systems and accessories), life science (liquid handling, cell culture, molecular biology, sample handling, and microbiology products), sample transport (diagnostic sample containers compliant with ADR/RID and IATA dangerous goods regulations), and laboratory automation (modular automation solutions for diagnostic laboratories with over 25 years of development experience). SARSTEDT's product portfolio includes screw-cap micro tubes (0.5–2.0 ml), reagent and centrifuge tubes, serological pipettes, micro test plates, cell culture flasks, Monovette® blood collection tubes, Microvette® capillary collection devices, and Urine Monovette® collection systems. Products are manufactured to stringent quality standards, certified as sterile, non-pyrogenic, endotoxin-free, non-cytotoxic, and free from DNA/DNase/RNase contamination. The company maintains over 13 production facilities and 30 sales organizations worldwide. SARSTEDT serves clinical laboratories, medical practices, research institutions, and diagnostic facilities. The company emphasizes user-focused design, safety, reproducibility, and compliance with international regulatory requirements.

Greiner Bio-One International GmbH is a global manufacturer of biotechnology, diagnostics, and medical device solutions serving clinical laboratories, research institutions, and in vitro diagnostics markets. With headquarters in Kremsmünster, Austria, and a US presence, the company operates 28 subsidiaries and manufacturing sites across Austria, Germany, Hungary, the United States, Brazil, and Thailand, employing over 2,300 staff. The company specializes in preanalytical and bioanalytical solutions, including venous and capillary blood collection systems, urine collection containers, and safety blood collection devices. Their VACUETTE® EVOPROTECT line represents next-generation safety blood collection technology. Greiner Bio-One also manufactures comprehensive laboratory consumables: sterile syringes, needles, IV sets, collection tubes, and sample handling equipment. In bioscience research, they supply cell culture products (including 3D magnetic cell culture solutions), microplates, cryopreservation systems, and high-throughput screening (HTS) imaging microplates designed for drug discovery and ADME studies. Their portfolio includes specialized products for mass cell culture and advanced research applications. The company emphasizes safety, quality, and sustainability; they have achieved ACT Ecolabel certification for over 127 products, reflecting eco-conscious manufacturing. Greiner Bio-One serves research laboratories, clinical diagnostics facilities, blood banks, and pharmaceutical/biotech companies globally. The organization maintains strong regulatory compliance and participates actively in international scientific conferences and laboratory diagnostic forums.

Ingersoll Rand Inc. is a multinational industrial company based in Davidson, North Carolina, specializing in flow creation and life science and industrial solutions. Formed in February 2020 through the spinoff of Ingersoll-Rand plc's industrial segment and merger with Gardner Denver, the company operates across two main segments: Industrial Technologies and Services, and Precision and Science Technologies. With a 160-year heritage, Ingersoll Rand provides compressed air and vacuum systems, fluid management solutions, material handling equipment, and power tools across over 40 global brands. The company serves diverse markets including pharma, life sciences, laboratories, aerospace, food and beverage, water treatment, environmental, electronics, and manufacturing. With 17,000+ employees and 65+ manufacturing sites worldwide, Ingersoll Rand focuses on energy efficiency, productivity, and sustainability in industrial and precision sectors.

Lighthouse Lab Services is a Charlotte, North Carolina–based full-service medical laboratory consulting, recruiting, and operational solutions firm. Founded in 2003 and expanded through strategic acquisitions including Elite Diagnostics (2019), the company serves as a comprehensive partner for laboratory startup, compliance, staffing, and operations management. Services include CLIA/COLA/CAP certification and compliance support, laboratory startup and design, specialized recruiting and medical director placement (serving 200+ CLIA-accredited labs nationwide), equipment procurement and instrument servicing with OEM components and FDA-certified engineers, test validation, quality management, revenue cycle management and payer contracting, LIS software solutions (Beacon LIS platform), and specialized molecular and toxicology laboratory solutions. The company specializes in infectious disease, pathology, molecular diagnostics, toxicology, and cytology. With a team of 150+ experts managing and supporting hundreds of laboratories across the United States, Lighthouse positions itself as the nation's largest dedicated medical laboratory consulting and recruiting firm.

CellSolutions LLC manufactures comprehensive liquid-based cytology platforms for clinical and research laboratories. The company specializes in sample collection, preservation, automated slide preparation, and digital image analysis solutions—primarily for gynecological and non-gynecological cytology applications. Product portfolio includes the CellSolutions 30 and F50 automated processors, the BestCyte digital imaging and screening system, the GluCyte manual preparation method, and proprietary preservative fluids. BestCyte delivers high-resolution whole-slide imaging with remote diagnostic capability, networked virtual slide storage, and AI-driven cell grouping and detection algorithms. All systems support HPV and molecular testing compatibility. The platform is designed for mid-sized labs and clinical settings requiring walk-away automation, specimen adequacy improvement, and efficient case management.

RQM+ is a global MedTech Contract Research Organization (CRO) headquartered in Cary, North Carolina, specializing in regulatory affairs, quality assurance, clinical trials, laboratory services, and reimbursement strategies for medical devices, in-vitro diagnostics, and software-enabled products. Founded in 2008 and rebranded following the 2020 acquisition of Maetrics, RQM+ provides comprehensive support throughout the product life cycle with a focus on regulatory compliance and market access. The company operates FDA-recognized laboratory services through Jordi Labs (offering materials testing and chemical characterization) and delivers flexible partnering models including full-service outsourcing, consulting, and staff augmentation. RQM+ serves 19 of the top 20 medical device companies and 7 of the top 10 IVD companies, with global presence across the U.S., Europe, and the U.K., leveraging proprietary technology platforms to accelerate time to market and reduce regulatory risk.